Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Why Aren't Investors More Excited About Pharmacyclics' FDA Approval?
Why Aren't Investors More Excited About Pharmacyclics' FDA Approval?
Why Aren't Investors More Excited About Pharmacyclics' FDA Approval?
Submitted by
admin
on November 16, 2013 - 1:15pm
Source:
Motley Fool
News Tags:
Pharmacyclics
Imbruvica
mantle cell lymphoma
Headline:
Why Aren't Investors More Excited About Pharmacyclics' FDA Approval?
Do Not Allow Advertisers to Use My Personal information